Rad 666 Rad+Tab



Indications and Reactions:

Role Indications Reactions
Primary
Renal Transplant 23.8%
Metastatic Renal Cell Carcinoma 20.6%
Liver Transplant 15.6%
Renal Cell Carcinoma 6.4%
Hypertension 4.5%
Glioblastoma Multiforme 4.2%
Multiple Myeloma 3.0%
Neoplasm Malignant 2.7%
Non-small Cell Lung Cancer 2.6%
Endometrial Cancer Metastatic 2.4%
Pain 2.4%
Renal Cancer Metastatic 2.4%
Diabetes Mellitus 1.9%
Hepatic Cancer Metastatic 1.4%
Neuroendocrine Carcinoma 1.4%
Breast Cancer Metastatic 1.2%
Gastric Cancer 0.9%
Prophylaxis 0.9%
Transitional Cell Carcinoma 0.9%
Neoplasm 0.8%
Vomiting 23.3%
Pyrexia 11.7%
Liver Transplant Rejection 5.8%
Urinary Tract Infection 5.8%
Pulmonary Embolism 5.4%
Thrombocytopenia 5.0%
Kidney Transplant Rejection 4.6%
Respiratory Failure 4.2%
Transplant Rejection 4.2%
White Blood Cell Count Increased 4.2%
General Physical Health Deterioration 3.3%
Malignant Neoplasm Progression 3.3%
Weight Decreased 3.3%
Pneumonia 2.9%
Death 2.5%
Diarrhoea 2.1%
Dyspnoea 2.1%
Hemiplegia 2.1%
Hyponatraemia 2.1%
Pancreatitis 2.1%
Secondary
Renal Transplant 39.6%
Liver Transplant 9.2%
Metastatic Renal Cell Carcinoma 7.4%
Hypertension 4.2%
Immunosuppression 3.7%
Oedema 3.5%
Diabetes Mellitus 3.2%
Prophylaxis 3.2%
Non-small Cell Lung Cancer 2.8%
Bursitis 2.7%
Neoplasm 2.7%
Pain 2.3%
Hypothyroidism 2.1%
Multiple Myeloma 2.1%
Renal Cell Carcinoma 2.1%
Vitamin Supplementation 2.1%
Colitis Ulcerative 1.8%
Hypercholesterolaemia 1.8%
Nausea 1.8%
Osteoporosis 1.8%
Vomiting 17.2%
Thrombocytopenia 13.2%
Pyrexia 10.9%
Urinary Tract Infection 9.8%
Weight Decreased 7.5%
Liver Transplant Rejection 5.7%
Leukopenia 4.6%
Oedema Peripheral 4.6%
Urosepsis 4.6%
Nausea 2.9%
Pneumonia Bacterial 2.3%
Pulmonary Embolism 2.3%
Renal Stone Removal 2.3%
Lymphocele 1.7%
Pneumonia 1.7%
Portal Hypertension 1.7%
Respiration Abnormal 1.7%
Syncope 1.7%
Thrombophlebitis Superficial 1.7%
Tooth Extraction 1.7%
Interacting
Breast Cancer Metastatic 100.0%
Pancreatitis 100.0%